- DNA Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
-
CORRESP Filing
Ginkgo Bioworks (DNA) CORRESPCorrespondence with SEC
Filed: 11 Feb 21, 12:00am
February 11, 2021
VIA EDGAR
United States Securities and Exchange Commission
Division of Corporate Finance
Office of Real Estate & Construction
100 F Street, NE
Washington, D.C. 20549
Attn: | Jonathan Burr |
Pamela Howell |
Re: | Soaring Eagle Acquisition Corp. |
Registration Statement on Form S-1 |
Filed December 23, 2020 |
File No. 333-251661 |
Ladies and Gentlemen:
On behalf of our client, Soaring Eagle Acquisition Corp. (the “Company”), we are writing to submit the Company’s responses to the comments of the staff of the Division of Corporation Finance of the United States Securities and Exchange Commission (the “Staff”) with respect to the above-referenced registration statement on Form S-1 filed on December 23, 2020 (the “Registration Statement”), contained in the Staff’s letter dated January 19, 2021 (the “Comment Letter”).
Each comment contained in the Comment Letter is printed below in bold and is followed by the Company’s response. All page references in the responses set forth below refer to page numbers in amendment no. 1 to the Registration Statement as filed on January 26, 2021 (the “Amendment”). Capitalized terms used but not defined herein have the meanings set forth in the Registration Statement.
Registration Statement on Form S-1 filed December 23, 2020
General
1. | We note your response to comment 1. We do not believe that aspects of your offering would comply with Nasdaq’s current listing standard, IM-5101-2. |
Response: The Company respectfully advises the Staff that it has revised the disclosure throughout the Amendment to remove the Company’s ability to effect a spin-off, which the Company believes brings all aspects of the offering into compliance with Nasdaq’s current listing standard.
United States Securities and Exchange Commission
February 11, 2021
Spin-Off, page 121
2. | We note your response to comment 2 and disclosure in the prospectus that you do not expect SpinCo to have any materially different terms than the terms of this offering. Please tell us what you mean by “materially different” and explain what terms may be different than this offering. |
Response: Further to the Company’s response to comment number 1 above, the Company has revised the disclosure throughout the Amendment to remove the Company’s ability to effect a spin-off.
If you have any questions related to this letter, please do not hesitate to contact Joel Rubinstein at (212) 819-7642, Jonathan Rochwarger at (212) 819-7643 or Daniel Nussen at (213) 620-7796 of White & Case LLP.
Sincerely,
/s/White & Case LLP
White & Case LLP
cc: | Eli Baker, Chief Financial Officer, Soaring Eagle Acquisition Corp. |
2